The COPD Optimiser

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions
COPD
Interventions
DEVICE

COPD Optimiser

Patients will receive enhanced usual medical care as determined by their physician. The study visit is a standard consultation supported by the COPD Optimiser webtool. The extra elements added to the COPD consultation are the use of the COPD Optimiser and a short questionnaire directly following the consultation on the patient's experience with the COPD Optimiser. Patients can additionally consent to two optional elements: 1) a determination of blood eosinophil count using a point of care test and 2) a brief interview on their experience with the COPD Optimiser. this tool creates an overview of fac- tors and characteristics that may be associated with suboptimal COPD and provides GOLD guideline-based management suggestions. Implementation of the COPD Optimiser will sup- port healthcare professionals in providing optimal care for their COPD patients by providing individualized GOLD-guided management suggestions.

Trial Locations (2)

9713GH

General practices in Netherlands, Groningen

GPRI, Groningen

Sponsors
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

General Practitioners Research Institute

NETWORK